Results 121 to 130 of about 827 (180)

NETWORK-BASED ATTACKS IN CLOUD COMPUTING IN 2020-2024 [PDF]

As the use of cloud technologies has increased in the past five years, the number of network attacks is also increasing. During 2020 to 2024, there are lot of changes in cloud technologies which led to various network attacks in the cloud computing ...
anguluri, yaswanth sai manikanta
core   +1 more source

Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations

Infection and Drug Resistance
Milo Gatti,1,2 Federico Pea1,2 1Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy; 2Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItalyCorrespondence ...
Gatti M, Pea F
doaj  

In vitro activity of sulbactam/durlobactam against extensively drug-resistant Acinetobacter baumannii isolates belonging to South American major clones

Journal of Global Antimicrobial Resistance, 2021
Carolina S. Nodari, Fernanda F. Santos, Mariana N.L. Kurihara, Tiago B. Valiatti, Rodrigo Cayô, Ana Cristina Gales   +5 more
doaj   +1 more source

In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers [PDF]

Bianco, Gabriele, Boattini, Matteo, Cavallo, Rossana, Comini, Sara, Costa, Cristina   +4 more
core   +1 more source

Successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> and Enterobacterales coinfection with sulbactam-durlobactam combined with aztreonam: a case report. [PDF]

AME Case Rep
Yang S, Cheng Z, Liu Y, Ni L, Wei C.
europepmc   +1 more source

Sulbactam-Durlobactam in the Treatment of Bloodstream Infection Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Case Series and Literature Review. [PDF]

J Clin Med
Li R, Duan L, Sun S, Li D, Peng Q, Shang Y.   +5 more
europepmc   +1 more source

Utilization of Heterocyclic Moieties for the Development of Anti-Microbial Agent to Combat Resistance [PDF]

Antimicrobial resistance (AMR) poses a significant global health challenge, threatening the effectiveness of current treatment regimens and necessitating the development of novel antimicrobial agents. This review provides a comprehensive overview of AMR,
Monika Barsagade
core   +1 more source

Successful Use of Sulbactam-Durlobactam in Treating Carbapenem-Resistant Acinetobacter baumannii Pneumonia and Sepsis After Liver Transplantation: A Case Report. [PDF]

Am J Case Rep
Xiong HF, Zhang WT, Liu Y, Hou F, Liu B, Cui TT, He ZY, Zhang X, Zhao R, Sun LY.   +9 more
europepmc   +1 more source

In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales. [PDF]

J Antimicrob Chemother, 2023
Fouad A, Nicolau DP, Gill CM.
europepmc   +1 more source

In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA [PDF]

Bianco, G., Boattini, M.
core   +1 more source